1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Asmaa Abdelfattah Elsayed: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Follow-up of NAFLD Patients With MRI-PDFF Empagliflozin 25 MG, Ursodeoxycholic acid, Pentoxifylline 400 MG - Diabetes Type 2, NAFLD | Phase 4 | Completed | Asmaa Abdelfattah Elsayed | 80 | 2020-12-01 | 2022-12-20 |
Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1)
Pentoxifylline (1) · Ursodeoxycholic Acid (1) · empagliflozin (1)
Egypt (1)